Hatch-Waxman Act of 1984
Legislation / Policy
A landmark US law that created a streamlined pathway for generic drugs at the FDA, waiving the need for generics to repeat full clinical trials but requiring bioequivalence, and introducing a 'first-to-file' exclusivity incentive.
Mentioned in 1 video
